Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated and just as effective as the current standard 14 day regimen, according to a study published this week in The Lancet. These findings have important implications for the treatment and elimination of vivax malaria in the Asia Pacific.

Dr Bob Taylor in a lab with colleagues at a South Sumatra, Indonesia IMPROV study site © 2019 MORU. Photographer: Prayoon Yuentrakul
Dr Bob Taylor, right, in a lab with colleagues at a South Sumatra, Indonesia IMPROV study site

Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study

Journal article

Firth C. et al, (2026), Human Vaccines & Immunotherapeutics, 22

Interrupted time-series analysis of nationwide surveillance in Thai adult pneumococcal diseases over 14 years: evidence to inform policy in resource-limited countries

Journal article

Ngamprasertchai T. et al, (2026), Expert Review of Vaccines, 25

Engaging youth in health and research in rural Cambodia: a qualitative study.

Journal article

Ean M. et al, (2026), Global health action, 19

Community and stakeholder engagement in national priority setting and participatory research for HIV, Tuberculosis, and Malaria programs in Nepal

Journal article

Neupane S. et al, (2026), Research Involvement and Engagement, 12

Strengthening health management information systems for Chagas disease: a multi-level qualitative study in Bolivia and Paraguay.

Journal article

Skjefte M. et al, (2026), Lancet regional health. Americas, 60

Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis

Journal article

Fadilah I. et al, (2026), The Lancet Regional Health - Western Pacific, 72, 101908 - 101908

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data

Journal article

Hagedoorn NN. et al, (2026), Vaccine, 85, 128691 - 128691

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

Cross- Wellcome Africa Asian Programmes (AAPs) Acceleration of Genomics for Escalating infectious Diseases, (CAGED) Consortium

Journal article

Kiyuka PK. et al, (2026), Wellcome Open Research, 11, 87 - 87

Comparison of in vitro antibiotic susceptibility testing of R. typhi using plaque assay and quantitative real-time PCR

Journal article

Phuklia W. et al, (2026), Microbiology Spectrum, 14

Association of Diabetes Mellitus With a Shared Hyperinflammatory Immune Response in Patients With Melioidosis and Patients With Tuberculosis: An Observational Case-Control Study

Journal article

Rongkard P. et al, (2026), Open Forum Infectious Diseases, 13

Mortality and Length of Stay Associated With Community-Acquired Escherichia coli and Staphylococcus aureus Bloodstream Infections: An Observational Study in 9 Low- and Middle-Income Countries

Journal article

Hopkins J. et al, (2026), Clinical Infectious Diseases

Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines

Journal article

Arman BY. et al, (2026), International Journal of Pharmaceutics: X, 11, 100467 - 100467

High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of Plasmodium vivax malaria: a safety study in Papua New Guinea and Indonesia

Journal article

Fransisca L. et al, (2026), The Lancet Regional Health - Western Pacific, 71, 101903 - 101903

Assessing transporter‐mediated rifampin–linezolid interaction using physiologically‐based pharmacokinetic modelling

Journal article

Nguyen HD. et al, (2026), British Journal of Clinical Pharmacology, 92, 1845 - 1856

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial

Journal article

Degaga TS. et al, (2026), The Lancet Infectious Diseases, 26, 614 - 626

Population pharmacokinetics of lumefantrine in pregnant and non-pregnant Nigerian women receiving efavirenz-based antiretroviral therapy.

Journal article

Akinrinade TO. et al, (2026), European journal of clinical pharmacology, 82

Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.

Journal article

Manesh A. et al, (2026), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 82, S105 - S115

Rickettsial seropositivity in Lao PDR smallholder livestock farms: Implications for animal and human health.

Journal article

Tawfik C. et al, (2026), One health (Amsterdam, Netherlands), 22

Load More

Similar stories